Clinical Trials Browser

Unknown × Breast Neoplasms × Gemcitabine × Clear all

NCT02341911 2022-04-20

TNBC

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04681911 2020-12-23

Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT04517292 2020-08-18

GEP

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04143906 2019-10-30

Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT03423849 2018-02-06

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy

Phase 2/3 Unknown

Breast Neoplasms

NCT00408408 2017-09-18

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Phase 3 Unknown

1,206 enrolled 19 charts

Breast Neoplasms

NCT03006614 2017-01-16

PERS

Phase 3 Unknown

Breast Neoplasms

NCT02207335 2015-12-22

Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT02544243 2015-09-09

Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00027989 2013-12-18

Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00070278 2013-08-07

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT01352494 2011-05-27

NeoTG

Phase 2 Unknown

Breast Neoplasms